{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:48:00Z","timestamp":1761490080720,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"OGAC, NIH, HRSA","award":["5R24TW008886"],"award-info":[{"award-number":["5R24TW008886"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["VR2011-7381"],"award-info":[{"award-number":["VR2011-7381"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1777-7","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T12:19:52Z","timestamp":1471609192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda"],"prefix":"10.1186","volume":"16","author":[{"given":"Moses","family":"Ocan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freddie","family":"Bwanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Okeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Katabazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Kigozi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Kyobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Ogwal-Okeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celestino","family":"Obua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"issue":"3","key":"1777_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.actatropica.2011.03.004","volume":"121","author":"A Yeka","year":"2012","unstructured":"Yeka A, Gasasira A, Mpimbaza A, Achan J, Nankabirwa J, Nsobya S, Staedke SG, Donnelly MJ, Wabwire-Mangen F, Talisuna A, et al. Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts. Acta Trop. 2012;121(3):184\u201395.","journal-title":"Acta Trop"},{"key":"1777_CR2","doi-asserted-by":"crossref","DOI":"10.30875\/c5be4728-en","volume-title":"World malaria report 2013","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. World malaria report 2013. Geneva: WHO; 2013."},{"issue":"2","key":"1777_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4269\/ajtmh.2006.75.219","volume":"75","author":"PE Okello","year":"2006","unstructured":"Okello PE, Van Bortel W, Byaruhanga AM, Correwyn A, Roelants P, Talisuna A, D\u2019 Alessandro U, Coosemans M. Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg. 2006;75(2):219\u201325.","journal-title":"Am J Trop Med Hyg"},{"key":"1777_CR4","first-page":"683167","volume":"2011","author":"M Nanyunja","year":"2011","unstructured":"Nanyunja M, Nabyonga Orem J, Kato F, Kaggwa M, Katureebe C, Saweka J. Malaria treatment policy change and implementation: the case of Uganda. Malar Res Treat. 2011;2011:683167.","journal-title":"Malar Res Treat"},{"key":"1777_CR5","first-page":"301","volume":"41","author":"NJ White","year":"1999","unstructured":"White NJ. Delaying antimalarial drug resistance with combination therapy. Parasitology. 1999;41:301\u20138.","journal-title":"Parasitology"},{"key":"1777_CR6","volume-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: WHO; 2014."},{"key":"1777_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"1777_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1473-3099(03)00657-1","volume":"3","author":"EL Korenromp","year":"2003","unstructured":"Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW. Measuring trends in childhood malaria mortality in Africa: a new assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis. 2003;3:349\u201358.","journal-title":"Lancet Infect Dis"},{"key":"1777_CR9","doi-asserted-by":"crossref","unstructured":"Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, Se Y, Chann S, Ittiverakul M, Siangam P, Kuntawunginn W, Arsanok M, Buathong N, Chaorattanakawee S, Gosi P, Ta-aksorn W, Chanarat N, Sundrakes S, Kong N, Heng TK, Nou S, Teja-isavadharm P, Pichyangkul S, Phann ST, Balasubramanian S, Juliano JJ, Meshnick SR, Chour CM, Prom S, Lanteri CA, Lon C, David L, Saunders DL. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. The Lancet Infectious Diseases. 2015;15(6):683\u2013691.","DOI":"10.1016\/S1473-3099(15)70049-6"},{"issue":"8","key":"1777_CR10","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1128\/AAC.03055-14","volume":"58","author":"C Amaratunga","year":"2014","unstructured":"Amaratunga C, Witkowski B, Dek D, Try V, Khim N, Miotto O, M\u00e9nard D, Fairhursta RM. Plasmodium falciparum Founder Populations in Western Cambodia have reduced artemisinin sensitivity in vitro. Antimicrob Agents Chemother. 2014;58(8):4935\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1777_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1073\/pnas.1006113108","volume":"108","author":"S Saralamba","year":"2011","unstructured":"Saralamba S, Pan-Ngum W, Maude RJ, Lee SJ, Tarning J, Lindeg\u00e5rdh N, Chotivanich K, Nosten F, Day NP, Socheat D, et al. Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A. 2011;108(1):397\u2013402.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5687","key":"1777_CR12","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.1098876","volume":"305","author":"C Roper","year":"2004","unstructured":"Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305(5687):1124.","journal-title":"Science"},{"key":"1777_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nature00813","volume":"418","author":"JC Wootton","year":"2002","unstructured":"Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature. 2002;418:320\u20133.","journal-title":"Nature"},{"issue":"5","key":"1777_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","volume":"211","author":"S Takala-Harrison","year":"2015","unstructured":"Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, Hien TT, Mayxay M, Noedl H, et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 2015;211(5):670\u20139.","journal-title":"J Infect Dis"},{"key":"1777_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4269\/ajtmh.1995.52.565","volume":"52","author":"CV Plowe","year":"1995","unstructured":"Plowe CV, Djimde A, Bouare M, Doumbo OK, Wellems TE. Pyrimethamine andproguanil resistance-conferring mutationsin Plasmodium falciparum dihydrofolatereductase: polymerase chain reaction methods for surveillance in Africa. Am J TropMed Hyg. 1995;52:565\u20138.","journal-title":"Am J TropMed Hyg"},{"key":"1777_CR16","doi-asserted-by":"crossref","unstructured":"Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989a;123:585\u2013595.","DOI":"10.1093\/genetics\/123.3.585"},{"issue":"1","key":"1777_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1534\/genetics.107.083006","volume":"179","author":"A Ram\u00edrez-Soriano","year":"2008","unstructured":"Ram\u00edrez-Soriano A, Ramos-Onsins SE, Rozas J, Calafell F, Navarro A. Statistical power analysis of neutrality tests under demographic expansions, contractions and bottlenecks with recombination. Genetics. 2008;179(1):555\u201367.","journal-title":"Genetics"},{"key":"1777_CR18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/genetics\/133.3.693","volume":"133","author":"YX Fu","year":"1993","unstructured":"Fu YX, Li WH. Statistical tests of neutrality of mutations. Genetics. 1993;133:693\u2013709.","journal-title":"Genetics"},{"issue":"6220","key":"1777_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gn\u00e4dig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, Dacheux M, Khim N, Zhang L, Lam S, Gregory PD, Urnov FD, Mercereau-Puijalon O, Benoit-Vical F, Fairhurst RM, M\u00e9nard D, Fidock DA. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347(6220):428\u2013431.","journal-title":"Science"},{"key":"1777_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1128\/AAC.01868-12","volume":"57","author":"B Witkowski","year":"2013","unstructured":"Witkowski B. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother. 2013;57:914\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"1777_CR21","doi-asserted-by":"publisher","first-page":"e93138","DOI":"10.1371\/journal.pone.0093138","volume":"9","author":"C Lon","year":"2014","unstructured":"Lon C, Manning JE, Vanachayangkul P, So M, Sea D, Se Y, Gosi P, Lanteri C, Chaorattanakawee S, Sriwichai S, et al. Efficacy of two versus three day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open label randomized trial. PLoS ONE. 2014;9:e93138.","journal-title":"PLoS ONE"},{"issue":"7481","key":"1777_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505(7481):50\u20135.","journal-title":"Nature"},{"issue":"1","key":"1777_CR23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/AAC.04144-14","volume":"59","author":"J Feng","year":"2015","unstructured":"Feng J, Li J, Yan H, Feng X, Xia Z. Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China. Antimicrob Agents Chemother. 2015;59(1):326\u201330.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"1777_CR24","doi-asserted-by":"publisher","first-page":"e105690","DOI":"10.1371\/journal.pone.0105690","volume":"9","author":"MD Conrad","year":"2014","unstructured":"Conrad MD, Bigira V, Kapisi J, Muhindo M, Kamya MR, Havlir DV, Dorsey G, Rosenthal PJ. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in plasmodium falciparum isolated from Ugandan children. PLoS ONE. 2014;9(8):e105690.","journal-title":"PLoS ONE"},{"issue":"11","key":"1777_CR25","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1086\/647946","volume":"49","author":"E Arinaitwe","year":"2009","unstructured":"Arinaitwe E, Wanzira TGSH, Kakuru A, Homsy J, Kalamya J, Kamya MR, Vora N, Greenhouse B, Rosenthal PJ, Tappero J, et al. Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin Infect Dis. 2009;49(11):1629\u201337.","journal-title":"Clin Infect Dis"},{"key":"1777_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1475-2875-13-32","volume":"13","author":"MK Muhindo","year":"2014","unstructured":"Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J. 2014;13:32.","journal-title":"Malar J"},{"issue":"8","key":"1777_CR27","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1128\/AAC.00921-15","volume":"59","author":"RA Cooper","year":"2015","unstructured":"Cooper RA, Conrad MD, Watson QD, Huezo SJ, Ninsiima H, Tumwebaze P, Nsobya SL, Rosenthal AS. Lack of artemisinin resistance in plasmodium falciparum in Uganda based on parasitological and molecular assays. Antimicrob Agents Chemother. 2015;59(8):5061\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"1777_CR28","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/infdis\/jiu467","volume":"211","author":"SM Taylor","year":"2015","unstructured":"Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, Tagbor H, Williams J, Bojang K, Njie F, et al. Absence of putative artemisinin resistance mutations among plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2015;211:680\u20138.","journal-title":"J Infect Dis"},{"key":"1777_CR29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s13071-015-1253-z","volume":"8","author":"B Huang","year":"2015","unstructured":"Huang B, Deng C, Yang T, Xue L, Wang Q, Huang S, Su X-Z, Liu Y, Zheng S, Guan Y, et al. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10\u00a0years after artemisinin combination therapy. Parasit Vectors. 2015;8:634.","journal-title":"Parasit Vectors"},{"issue":"1","key":"1777_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1128\/AAC.01346-15","volume":"60","author":"A Boussaroque","year":"2016","unstructured":"Boussaroque A, Fall B, Madamet M, Camara C, Benoit N, Fall M, Nakoulima A, Dionne P, Fall KB, Diatta B, Di\u00e9m\u00e9 Y, Wade B, Pradines B. Emergence of Mutations in the K13 Propeller Gene of Plasmodium falciparum Isolates from Dakar, Senegal, in 2013\u20132014. Antimicrobial Agents and Chemotherapy. 2016;60(1):624\u2013627.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"1777_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, Lin K, Kyaw MP, Plewes K, Faiz MA, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular markrer. Lancet Infect Dis. 2015;15:415\u201321.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"1777_CR32","doi-asserted-by":"publisher","first-page":"e92323","DOI":"10.1371\/journal.pone.0092323","volume":"9","author":"M Ocan","year":"2014","unstructured":"Ocan M, Bwanga F, Bbosa GS, Bagenda D, Waako P, Ogwal-Okeng J, Obua C. Patterns and predictors of self-medication in Northern Uganda. PLoS ONE. 2014;9(3):e92323.","journal-title":"PLoS ONE"},{"key":"1777_CR33","volume-title":"Implementation Guidelines for Home-Based Management of Fever Strategy in Children","author":"Uganda Ministry of Health","year":"2005","unstructured":"Uganda Ministry of Health. Implementation Guidelines for Home-Based Management of Fever Strategy in Children. 2nd ed. Kampala: MOH; 2005.","edition":"2"},{"key":"1777_CR34","volume-title":"National guidelines for management of common conditions","author":"Uganda Clinical Guidelines","year":"2012","unstructured":"Uganda Clinical Guidelines. National guidelines for management of common conditions. Kampala: Ministry of Health; 2012."},{"key":"1777_CR35","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1073\/pnas.96.3.1152","volume":"96","author":"DJ Austin","year":"1999","unstructured":"Austin DJ, Kristinnson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and frequency of resistance. Proc Natl Acad Sci U S A. 1999;96:1152\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1777_CR36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.pt.2004.08.006","volume":"20","author":"IM Hastings","year":"2004","unstructured":"Hastings IM. The origins of antimalarial drug resistance. Trends Parasitol. 2004;20:512\u20138.","journal-title":"Trends Parasitol"},{"key":"1777_CR37","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(10)61963-0","volume":"376","author":"NJ White","year":"2010","unstructured":"White NJ. Artemisinin resistance-the clock is ticking. Lancet. 2010;376:2051\u20132.","journal-title":"Lancet"},{"key":"1777_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.actatropica.2005.04.010","volume":"94","author":"TJ Anderson","year":"2005","unstructured":"Anderson TJ, Roper C. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop. 2005;94:269\u201380.","journal-title":"Acta Trop"},{"key":"1777_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/hdy.2012.12","volume":"109","author":"WP Goodall-Copestake","year":"2012","unstructured":"Goodall-Copestake WP, Tarling GA, Murphy EJ. On the comparison of population level estimates of haplotype and nucleotide diversity: a case study using the gene Cox 1 in animals. Heredity. 2012;109:50\u20136.","journal-title":"Heredity"},{"key":"1777_CR40","doi-asserted-by":"publisher","first-page":"e1000304","DOI":"10.1371\/journal.pgen.1000304","volume":"4","author":"S Kryazhimskiy","year":"2008","unstructured":"Kryazhimskiy S, Plotkin JB. The population genetics of dN\/dS. PLoS Genet. 2008;4:e1000304.","journal-title":"PLoS Genet"},{"key":"1777_CR41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s13059-014-0544-6","volume":"15","author":"EA Winzeler","year":"2014","unstructured":"Winzeler EA, Manary MJ. Drug resistance genomics of the antimalarial drug artemisinin. Genome Biol. 2014;15:544.","journal-title":"Genome Biol"},{"issue":"2","key":"1777_CR42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/MMBR.60.2.301-315.1996","volume":"60","author":"SR Meshnick","year":"1996","unstructured":"Meshnick SR, Taylor TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev. 1996;60(2):301\u201315.","journal-title":"Microbiol Rev"},{"issue":"7","key":"1777_CR43","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.3390\/ph3072322","volume":"3","author":"Q Li","year":"2010","unstructured":"Li Q, Weina P. Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria. Pharmaceuticals (Basel). 2010; 3(7):2322\u20132332.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1777_CR44","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(05)67787-2","volume":"366","author":"R Jambou","year":"2005","unstructured":"Jambou R. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005;366:1960\u20133.","journal-title":"Lancet"},{"key":"1777_CR45","doi-asserted-by":"publisher","first-page":"e1001398","DOI":"10.1371\/journal.pmed.1001398","volume":"10","author":"VI Carrara","year":"2013","unstructured":"Carrara VI, Lwin KM, Phyo AP, Ashley EA, Wiladphaingern J, Sriprawat K, Rijken M, Boel M, McGready R, Proux S, et al. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999\u20132011: an observational study. PLoS Med. 2013;10:e1001398.","journal-title":"PLoS Med"},{"issue":"4","key":"1777_CR46","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, Price RN, M\u00e5rtensson A, Rosenthal PJ, Dorsey G, et al. Polymorphisms in plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine. Am J Trop Med Hyg. 2014;91(4):833\u201343.","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"1777_CR47","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/cid\/cir066","volume":"52","author":"BE Ngasala","year":"2011","unstructured":"Ngasala BE, Malmberg M, Carlsson AM, Ferreira PE, Petzold MG, Blessborn D, Bergqvist Y, Gil JP, Premji Z, Bj\u00f6rkman A, et al. Efficacy and effectiveness of Artemether-Lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated plasmodium falciparum malaria in Rural Tanzania: a randomized trial. Clin Infect Dis. 2011;52(7):873\u201382.","journal-title":"Clin Infect Dis"},{"key":"1777_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1475-2875-10-231","volume":"10","author":"J Song","year":"2011","unstructured":"Song J, Socheat D, Tan B, Seila S, Xu Y, Ou F, Sokunthea S, Sophorn L, Zhou C, Deng C, et al. Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area. Malar J. 2011;10:231.","journal-title":"Malar J"},{"issue":"2","key":"1777_CR49","first-page":"326","volume":"8","author":"A Awad","year":"2005","unstructured":"Awad A, Eltayeb I, Matowe L, Thalib L. Self-medication with Antibiotics and Antimalarials in the community of Khartoum State, Sudan. J Pharm Pharmaceut Sci. 2005;8(2):326\u2013331.","journal-title":"Sudan. J Pharm Pharmaceut Sci."},{"key":"1777_CR50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, et al. Spread of artemisinin resistance in plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"1777_CR51","doi-asserted-by":"crossref","unstructured":"WWARN Parasite Clearance Study Group. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis. Malaria Journal. 2015;14:359","DOI":"10.1186\/s12936-015-0874-1"},{"key":"1777_CR52","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/infdis\/jit082","volume":"207","author":"TM Lopera-Mesa","year":"2013","unstructured":"Lopera-Mesa TM, Doumbia S, Chiang S, Zeituni AE, Konate DS, Doumbouya M, Keita AS, Stepniewska K, Traore K, Diakite SA, et al. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity. J Infect Dis. 2013;207:1655\u201363.","journal-title":"J Infect Dis"},{"issue":"2","key":"1777_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/infdis\/jiu427","volume":"211","author":"PA Ndour","year":"2015","unstructured":"Ndour PA, Lopera-Mesa TM, Diakit\u00e9 SAS, Chiang S, Mouri O, Roussel C, Jaur\u00e9guiberry S, Biligui S, Kendjo E, Claessens A, et al. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria. J Infect Dis. 2015;211(2):290\u20137.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1777-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1777-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1777-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1777-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T19:01:21Z","timestamp":1657134081000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1777-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,19]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1777"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1777-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2016,8,19]]},"article-number":"428"}}